# RAMBAM 021: Safety and Initial Feasibility of the Neurolyser XR for the Treatment of Chronic Low Back Pain

> **NCT04519541** · NA · COMPLETED · sponsor: **FUSMobile Inc.** · enrollment: 10 (actual)

## Conditions studied

- Facet Syndrome of Lumbar Spine

## Interventions

- **DEVICE:** Non-Invasive Thermal Ablation of the Medial Branch Nerves using the Neurolyser XR

## Key facts

- **NCT ID:** NCT04519541
- **Lead sponsor:** FUSMobile Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-03
- **Primary completion:** 2022-09-11
- **Final completion:** 2023-01-31
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04519541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04519541, "RAMBAM 021: Safety and Initial Feasibility of the Neurolyser XR for the Treatment of Chronic Low Back Pain". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04519541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*